| Quest for correlates of protection against tuberculosis K Bhatt, S Verma, JJ Ellner, P Salgame Clinical and Vaccine Immunology 22 (3), 258-266, 2015 | 160 | 2015 |
| Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4 M de la Fuente, DN Noble, S Verma, MT Nieman Journal of Biological Chemistry 287 (13), 10414-10423, 2012 | 42 | 2012 |
| Synergistic lethality of a binary inhibitor of Mycobacterium tuberculosis KasA P Kumar, GC Capodagli, D Awasthi, R Shrestha, K Maharaja, P Sukheja, ... MBio 9 (6), 10.1128/mbio. 02101-17, 2018 | 38 | 2018 |
| Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains A Lovey, S Verma, V Kaipilyawar, R Ribeiro-Rodrigues, S Husain, ... Nature communications 13 (1), 884, 2022 | 34 | 2022 |
| Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology S Verma, K Bhatt, A Lovey, R Ribeiro-Rodrigues, J Durbin, ... PLoS pathogens 15 (3), e1007613, 2019 | 32 | 2019 |
| Grb2-associated binding (Gab) proteins in hematopoietic and immune cell biology TY Vaughan, S Verma, KD Bunting American journal of blood research 1 (2), 130, 2011 | 27 | 2011 |
| Toll-like receptor 2 prevents neutrophil-driven immunopathology during infection with Mycobacterium tuberculosis by curtailing CXCL5 production A Gopalakrishnan, J Dietzold, S Verma, M Bhagavathula, P Salgame Infection and immunity 87 (3), 10.1128/iai. 00760-18, 2019 | 24 | 2019 |
| Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets S Verma, P Du, D Nakanjako, S Hermans, J Briggs, L Nakiyingi, JJ Ellner, ... BMC infectious diseases 18, 1-13, 2018 | 22 | 2018 |
| Divergent functions of TLR2 on hematopoietic and nonhematopoietic cells during chronic Mycobacterium tuberculosis infection J Konowich, A Gopalakrishnan, J Dietzold, S Verma, K Bhatt, W Rafi, ... The Journal of Immunology 198 (2), 741-748, 2017 | 12 | 2017 |
| Tuberculosis—Learning the Impact of Nutrition (TB LION): protocol for an interventional study to decrease TB risk in household contacts C Cintron, PB Narasimhan, L Locks, S Babu, P Sinha, N Rajkumari, ... BMC infectious diseases 21, 1-12, 2021 | 11 | 2021 |
| Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection K Bhatt, M Bhagavathula, S Verma, GS Timmins, VP Deretic, JJ Ellner, ... Disease models & mechanisms 14 (10), dmm049018, 2021 | 10 | 2021 |
| Gab adapter proteins as therapeutic targets for hematologic disease S Verma, T Vaughan, KD Bunting Advances in Hematology 2012 (1), 380635, 2012 | 10 | 2012 |
| QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA RL Epstein, M Bhagavathula, LA Saag, S Verma, CK Kan, J Mesick, ... The International Journal of Tuberculosis and Lung Disease 23 (4), 482-490, 2019 | 7 | 2019 |
| Epidemiologically characterized high and low transmission isolates of Mycobacterium tuberculosis induce distinct infection outcomes in mice S Verma, K Bhatt, RR Rodrigues, EC Jones-López, M Palaci, D Alland, ... The Journal of Immunology 196 (1_Supplement), 65.11-65.11, 2016 | 1 | 2016 |
